Karabelas Argeris N
CIK 0001191229
Director
Filings
11
Latest Jun 2, 2026
Issuers covered
2
Showing
11 of 11
Page 1
Track record
8 of 8 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 8 | 88% | +10.6% | +15.3% | +18.0% | -28.7% |
| 90 days | 8 | 100% | +24.2% | +31.4% | +34.6% | +5.2% |
| 180 days | 8 | 100% | +41.9% | +42.9% | +47.8% | +30.0% |
| 365 days | 8 | 100% | +26.6% | +32.1% | +41.4% | +4.3% |
Issuers
Companies where Karabelas Argeris N has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| RGNX | Regenxbio Inc. | 10 | Jun 2, 2026 |
| BHC | Bausch Health Companies Inc. | 1 | Jun 28, 2022 |
All filings
11 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|